January 2019 IMM investor update states cash runway through to mid 2020. It also states that AIPAC data was on track for end of CY 2019.
AIPAC results now due Q1 2020 - recruitment slippage no fault of company.
Additional trials - Tacti 002 moving quickly and likely to increase numbers/cohorts. Insight new combo's and 761 trial on the horizon
No partner milestone payments received FY19 ($6m may have been factored in FY19 from GSK?).
Estimated cash - end of FY June 30 - est $15m
Cash burn projected (imo) - est $6m per qtr Sept/Dec/Mar = $18m.
So in theory - cash may have lasted through to mid 2020 IF milestone payment(s) received and other opportunities (Tacti 002 etc) not taken up.
Additional $10m will be enough to prove 'beyond doubt' the value of EFTI.....FWIW - I'm in - last chance saloon though for me.
Ann: Trading Halt, page-227
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |